CVSG.L

CVS Group Plc
CVS Group plc - Long Term Incentive Plan Awards and PDMR Dealing
4th October 2024, 16:11
TwitterFacebookLinkedIn
To continue viewing RNS, please confirm that you are a Private Investor*

* A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:

  1. Obtains access to the information in a personal capacity;
  2. Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
  3. Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
  4. Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
  5. Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
  6. Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
RNS Number : 0657H
CVS Group plc
04 October 2024
 

For immediate release                                                                                  4 October 2024

CVS GROUP plc

("CVS", the "Company" or the "Group")

Long Term Incentive Plan Awards and PDMR Dealing

 

CVS, the UK listed veterinary group and a leading provider of veterinary services, announces that it has granted option awards over a total of 197,820 of the Company's ordinary shares of 0.2 pence each ("Ordinary Shares") under the CVS Group Long Term Incentive Plan 2024 ("LTIP 18") (the "Options").  Certain of the Options were awarded to the Directors named below, with the balance being issued to certain other employees.

 

Name                                  Role                                                         Number of Options

Richard Fairman                 Chief Executive Officer                             55,581

Robin Alfonso                     Chief Financial Officer                              30,460

Paul Higgs                           Chief Veterinary Officer                            26,144

 

The awards will vest in three years' time, subject to performance criteria being satisfied.  These vesting criteria relate to the Company's earnings per share growth and total shareholder return over the three-year period between 1 July 2024 and 30 June 2027.

The notification below, made in accordance with the requirements of UK MAR, provides further detail.

 

CVS Group plc                                                                                                    via Camarco

Richard Fairman, CEO

Scott Morrison, Company Secretary

 

Peel Hunt LLP (Nominated Adviser & Joint Broker)                          +44 (0)20 7418 8900

Christopher Golden / James Steel / Andrew Clark / Lalit Bose

 

  Berenberg (Joint Broker)                                                                      +44 (0)20 3207 7800

Toby Flaux / Ben Wright / James Thompson / Milo Bonser

 

Camarco (Financial PR)                                                                                             

Ginny Pulbrook                                                                                       +44 (0)7961 315 138

Geoffrey Pelham-Lane                                                                            +44 (0)7733 124 226

 

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

 

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Richard Fairman

2

Reason for the notification

a)

Position/status

Chief Executive Officer

b)

Initial notification /Amendment

Initial Notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

CVS Group plc

b)

LEI

213800J41XDQ2NX48O05

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

 

Identification code

Options over Ordinary shares of 0.2 pence each

 

 

 

GB00B2863827

b)

Nature of the transaction

Grant of Options under LTIP 18.

c)

Price(s) and volume(s)

Price(s)

Volume(s)

Exercise price of 0.2p

55,581

 

 

 

d)

Aggregated information

 

- Aggregated volume

 

 

- Price

 

 N/A

e)

Date of the transaction

4 October 2024

f)

Place of the transaction

Off market

 

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Robin Alfonso

2

Reason for the notification

a)

Position/status

Chief Financial Officer

b)

Initial notification /Amendment

Initial Notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

CVS Group plc

b)

LEI

213800J41XDQ2NX48O05

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

 

Identification code

Options over Ordinary shares of 0.2 pence each

 

 

 

GB00B2863827

b)

Nature of the transaction

Grant of Options under LTIP 18.

c)

Price(s) and volume(s)

Price(s)

Volume(s)

Exercise price of 0.2p

30,460

 

 

 

d)

Aggregated information

 

- Aggregated volume

 

 

- Price

 

  N/A

e)

Date of the transaction

4 October 2024

f)

Place of the transaction

Off market

 

 

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Paul Higgs

2

Reason for the notification

a)

Position/status

Chief Veterinary Officer

b)

Initial notification /Amendment

Initial Notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

CVS Group plc

b)

LEI

213800J41XDQ2NX48O05

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

 

Identification code

Options over Ordinary shares of 0.2 pence each

 

 

 

GB00B2863827

b)

Nature of the transaction

Grant of Options under LTIP 18.

c)

Price(s) and volume(s)

Price(s)

Volume(s)

Exercise price of 0.2p

26,144

 

 

 

d)

Aggregated information

 

- Aggregated volume

 

 

- Price

 

 N/A

e)

Date of the transaction

4 October 2024

f)

Place of the transaction

Off market

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHUSRNRSKURRAA]]>
TwitterFacebookLinkedIn